Status:
UNKNOWN
Near Infrared Spectroscopy Neurofeedback Training for ADHD
Lead Sponsor:
North Essex Partnership NHS Foundation Trust
Collaborating Sponsors:
University College, London
Hertfordshire Community NHS Trust
Conditions:
Attention Deficit/Hyperactivity Disorder
Eligibility:
All Genders
7-17 years
Phase:
NA
Brief Summary
Background Attention Deficit Hyperactivity Disorder (ADHD) is one of the most frequently diagnosed behavioural disorders in childhood that requires treatment(3-5% of children). It is an important heal...
Detailed Description
ADHD is one of the most frequently diagnosed conditions in childhood and at least half of patients have symptoms that persist into adulthood. It is important to seek effective treatments for ADHD beca...
Eligibility Criteria
Inclusion
- Patients diagnosed with ADHD aged 7 to 17 years
- Patient and legal guardian able to communicate in English
- Patient has been living with parent/guardian for at least six months
- Patient attending school for at least 2 days / week
- ADHD as primary disorder with symptoms present for at least 9 months
- Participants on medication treatment for ADHD must have been on a stable dose for 3 months prior to commencement of the treatment
Exclusion
- Significant visual or hearing impairment that would preclude use of NIRS- neurofeedback
- Global learning disability, Autism, psychosis, bipolar disorder, depression, suicidal ideation, or another psychiatric disorder requiring treatment with additional psychotropic medication, current substance dependance or regular use, and severe sleep disorders
Key Trial Info
Start Date :
March 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT02205268
Start Date
March 1 2013
Last Update
October 14 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aylmer House
Harlow, Essex, United Kingdom, CM20 1DL